Download
Download by
Scanning QR Code
  • Download app

    Download app

+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
002022 Shanghai Kehua Bio-engineering
10.280
+0.030+0.29%
YOY
Do not show
Hide blank lines
(Q3)2023/03/31(FY)2022/12/31(Q9)2022/09/30(Q6)2022/06/30
Total operating revenue
98.13% 833.15M 43.58% 6.97B 44.40% 5.38B -62.38% 902.93M
Operating revenue
98.13% 833.15M 43.58% 6.97B 44.40% 5.38B -62.38% 902.93M
Other operating revenue
-- -- 411.28% 54.29M -- -- 744.05% 10.3M
Total operating cost
88.88% 736.27M 47.61% 4.79B 33.59% 3.15B -44.93% 827.79M
Operating cost
87.75% 442.54M 49.86% 3.31B 48.09% 2.31B -48.66% 512.16M
Operating tax surcharges
41.13% 3.84M 56.02% 54.35M 62.33% 45.03M -69.61% 4.96M
Operating expense
72.67% 128.49M 48.38% 765.37M -0.08% 457.65M -47.72% 152.21M
Administration expense
81.29% 81.31M 67.57% 492.62M 33.48% 264.37M -23.53% 97.25M
Financial expense
59.36% 14.28M -278.76% -80.15M -426.26% -85M 2.86% 19.88M
-Interest expense (Financial expense)
-21.90% 10.25M -0.21% 40.06M 1.25% 29.07M -3.88% 19.1M
-Interest Income (Financial expense)
-241.18% -7.95M -65.59% -44.36M -67.51% -30.03M 76.83% -3.12M
Research and development
184.26% 65.81M 68.71% 250.49M 78.47% 157.61M -20.12% 41.33M
Credit Impairment Loss
330.48% 2.34M -472.31% -73.33M -163.42% -36.56M 71.19% -1.41M
Asset Impairment Loss
-89.59% 813.57K -1,736.88% -242.92M 206.54% 5.2M 295.29% 7.79M
Other net revenue
127.07% 20.21M -463.34% -115.25M 1,168.54% 47.15M 4,969.39% 9.2M
Invest income
-- 7.01M 298.81% 3.9M -- -- -- --
Asset deal income
-394.34% -507.09K 120.20% 4.53M 52.85% 1.29M 35.44% 207.36K
Other revenue
447.61% 10.55M 233.98% 192.58M 227.25% 77.22M -44.53% 2.62M
Operating profit
195.73% 117.09M 25.81% 2.07B 66.07% 2.28B -90.59% 84.34M
Add:Non operating Income
1,006.78% 287.64K 260.84% 2.49M 7.59% 714.34K -95.26% 18.06K
Less:Non operating expense
12,458.73% 1.03M -47.55% 2.51M 149.60% 2.04M -32.95% 266.2K
Total profit
193.73% 116.35M 26.13% 2.07B 65.99% 2.27B -90.62% 84.09M
Less:Income tax cost
145.62% 19.17M 17.71% 333.81M 52.66% 342.4M -88.48% 17.86M
Net profit
205.53% 97.17M 27.89% 1.73B 68.60% 1.93B -91.07% 66.23M
Net profit from continuing operation
205.53% 97.17M 27.89% 1.73B 68.60% 1.93B -91.07% 66.23M
Less:Minority Profit
345.43% 42.41M 51.07% 760.52M 77.52% 739.99M -92.45% 19.8M
Net profit of parent company owners
145.75% 54.76M 14.16% 970.85M 63.50% 1.19B -90.31% 46.43M
Earning per share
Basic earning per share
145.96% 0.1065 14.09% 1.8878 63.39% 2.3178 -90.31% 0.0903
Diluted earning per share
99.81% 0.1065 13.86% 1.8206 61.91% 2.2102 -87.72% 0.1102
Other composite income
31.33% -2.29M 136.45% 8.63M 85.67% -3.38M 87.90% -1.88M
Other composite income of parent company owners
0.99% -1.93M 134.21% 6.57M 93.67% -1.19M 102.96% 368.3K
Other composite income of minority owners
74.08% -359.23K 146.04% 2.06M 53.53% -2.18M 27.82% -2.25M
Total composite income
233.32% 94.88M 30.81% 1.74B 71.84% 1.93B -91.13% 64.35M
Total composite income of parent company owners
159.85% 52.83M 17.59% 977.41M 67.67% 1.19B -89.97% 46.8M
Total composite income of minority owners
416.90% 42.05M 52.84% 762.59M 79.02% 737.81M -93.23% 17.55M
Currency Unit
CNYCNYCNYCNY
Accounting Standards
CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions
--Unqualified opinion----
Auditor
--Dahua Certified Public Accountants (Special General Partnership)----

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Research, production and operation of biochemical reagents, clinical diagnostic reagents, medical devices, veterinary injections, biochemical reagent testing tools, genetically-engineered drugs, microbiological environmentally friendly products, leasing of own equipment and related technical services, and is engaged in the import and export of goods and technology import and export business (except for goods and technology restricted to or prohibited by the country).
CEO: --
Market: --
Listing Date: 07/21/2004
Futu Hot List
CNHKUS
SearchNews
SymbolLatest price%Chg

Loading...

Watchlist